AU2003265420A1 - Polypeptide multimers having antiviral activity - Google Patents

Polypeptide multimers having antiviral activity

Info

Publication number
AU2003265420A1
AU2003265420A1 AU2003265420A AU2003265420A AU2003265420A1 AU 2003265420 A1 AU2003265420 A1 AU 2003265420A1 AU 2003265420 A AU2003265420 A AU 2003265420A AU 2003265420 A AU2003265420 A AU 2003265420A AU 2003265420 A1 AU2003265420 A1 AU 2003265420A1
Authority
AU
Australia
Prior art keywords
antiviral activity
polypeptide multimers
multimers
polypeptide
antiviral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003265420A
Inventor
Eve De Rosny
Yong He
Russell Vassell
Carol D. Weiss
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services filed Critical US Department of Health and Human Services
Publication of AU2003265420A1 publication Critical patent/AU2003265420A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1063—Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/64—Medicinal preparations containing antigens or antibodies characterised by the architecture of the carrier-antigen complex, e.g. repetition of carrier-antigen units
    • A61K2039/645—Dendrimers; Multiple antigen peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
    • G01N2333/155—Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV
    • G01N2333/16—HIV-1, HIV-2
    • G01N2333/162—HIV-1, HIV-2 env, e.g. gp160, gp110/120, gp41, V3, peptid T, DC4-Binding site
AU2003265420A 2003-08-14 2003-08-14 Polypeptide multimers having antiviral activity Abandoned AU2003265420A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2003/025295 WO2005018666A1 (en) 2003-08-14 2003-08-14 Polypeptide multimers having antiviral activity

Publications (1)

Publication Number Publication Date
AU2003265420A1 true AU2003265420A1 (en) 2005-03-10

Family

ID=34215307

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003265420A Abandoned AU2003265420A1 (en) 2003-08-14 2003-08-14 Polypeptide multimers having antiviral activity

Country Status (2)

Country Link
AU (1) AU2003265420A1 (en)
WO (1) WO2005018666A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100339396C (en) * 2005-04-18 2007-09-26 中国科学院微生物研究所 Multi-helix protein for inhibiting membrane virus infection, its coding gene and use
JP2008029239A (en) * 2006-07-27 2008-02-14 Gekkeikan Sake Co Ltd Method for producing n36-binding peptide
US9381226B2 (en) 2007-02-08 2016-07-05 University Of Utah Research Foundation Methods and compositions related to inhibition of viral entry
EP2188303B1 (en) 2007-09-07 2011-12-21 Complix N.V. Non-natural proteinaceous scaffold made of three non-covalently associated peptides
EP2078726A1 (en) * 2008-01-09 2009-07-15 Vision 7 GmbH Secretable HIV entry inhibitory peptides for therapy of HIV infection
GB2471692A (en) * 2009-07-08 2011-01-12 Complix Nv HIV gp41-binding single-chain coiled-coil peptide comprising heptad repeats
CA2868735C (en) 2011-03-28 2020-02-25 University Of Utah Research Foundation D-peptide conjugates comprising a membrane localizing potency-enhancing cargo molecule for inhibiting hiv entry
CN109069577B (en) 2016-01-07 2022-08-19 纳维根公司 D-peptide inhibitors of HIV entry and methods of use
WO2019241557A1 (en) * 2018-06-15 2019-12-19 The Regents Of The University Of California Fusion fragment chimeric antigen receptors and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2140663C (en) * 1992-07-20 2004-01-27 Carl T. Wild Compounds which inhibit hiv replication
US5464933A (en) * 1993-06-07 1995-11-07 Duke University Synthetic peptide inhibitors of HIV transmission
US20030082525A1 (en) * 1999-12-16 2003-05-01 Whitehead Institute For Biomedical Research Five-Helix protein
EP1237912B1 (en) * 1999-12-16 2007-12-12 Whitehead Institute For Biomedical Research Five-helix protein

Also Published As

Publication number Publication date
WO2005018666A1 (en) 2005-03-03

Similar Documents

Publication Publication Date Title
AU2003255831A1 (en) Delayed-gelation solution
AUPS134802A0 (en) Attachment system
AU2003268055A1 (en) Distributed computations
AU2003302205A1 (en) Joystick controller
AU2003289742A1 (en) Stable therapeutic proteins
AU2002951144A0 (en) Aquatic activity garment
AU2003272454A1 (en) Protein purification
AU2003231947A1 (en) Defensins: use as antiviral agents
AU2003229657A1 (en) Triazolopyrimidines
AU2003265420A1 (en) Polypeptide multimers having antiviral activity
AU2003213747A1 (en) Interaction design system
AU2003264296A1 (en) Rescue arrangement
AU2003286594A1 (en) Quinolones with anti-hiv activity
AU2003297381A1 (en) Attachment means
AU2003295462A1 (en) Lipid-associated proteins
AU2003266686A1 (en) Area dividing system
AU2003260148A1 (en) Aquarium
AU2003214445A1 (en) Tableware
AU2003302330A1 (en) Antimicrobial peptides
AU2003274695A1 (en) Location system
AU2003202694A1 (en) Torero protein
AU2003270055A1 (en) Neurotransmission-associated proteins
AU2003278718A1 (en) Stars-a muscle-specification-binding protein
AU2003284482A1 (en) Area dividing system
AU2003221419A1 (en) Use limit system

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase